Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BAY-0069 is a peroxisome proliferator-activated receptor γ (PPARγ) inverse agonist.1 It acts as an inverse agonist in a co-repressor reporter assay with a peptide from nuclear receptor co-repressor 2 (NCOR2; EC50 = 9.6 nM). BAY-0069 selectively induces PPARγ- over PPARα- or PPARδ-mediated gene transcription in reporter assays using CHO cells (IC50s = 6.3, 7,500, and 9,000 nM for the human receptors, respectively). BAY-0069 inhibits the proliferation of UM-UC-9 human bladder cancer cells that endogenously contain a focal amplification of PPARG, the gene encoding PPARγ (IC50 = 2.5 nM). In vivo, BAY-0069 (75 mg/kg, i.p.) decreases intratumoral mRNA expression of the PPARγ target gene FABP4, the gene encoding fatty acid binding protein 4, in a UM-UC-9 mouse xenograft model.
WARNING This product is not for human or veterinary use.
1. Discovery and structure-